JS
DPLO

Jeffrey Smith’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Jeffrey Smith’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-170,000
Closed -$7.61M – 42
2015
Q2 		$7.61M Buy
+170,000
New +$6.4M 0.17% 30

Other funds holding DPLO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jeffrey Smith's DPLO Position: Q3 2015 in Review

Jeffrey Smith sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2015, closing a stake of 170,000 shares — an estimated $7.61M sold.

Jeffrey Smith first reported a position in DPLO in Q2 2015 and held it in 1 quarter. The position peaked at $7.61M in Q2 2015. 130 funds tracked by Wall St. Rank hold DPLO as of Q3 2015.

  • Jeffrey Smith reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2015 after selling out during the quarter.
  • Jeffrey Smith sold 170,000 DIPLOMAT PHARMACY, INC. shares in Q3 2015, an estimated $7.61M.
  • Jeffrey Smith first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 1 quarter.
  • Jeffrey Smith's DIPLOMAT PHARMACY, INC. position peaked at $7.61M in Q2 2015.
  • 130 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2015.

Based on Starboard Value's 13F filing for Q3 2015, filed 13 Nov 2015.